Previous close | 4.1510 |
Open | 4.0320 |
Bid | 3.8350 x N/A |
Ask | 3.9400 x N/A |
Day's range | 4.0320 - 4.0320 |
52-week range | 3.7410 - 13.0000 |
Volume | |
Avg. volume | 13 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Visionary founder and investor brings decades of experience building and scaling digital consumer brandsDELRAY BEACH, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company") today announced the appointment of Leah Solivan to the Company’s Board of Directors (“the Board”), effective June 24, 2024. Solivan brings over 20 years of experience building and scaling technology businesses to the Company’s Board. As a Gener
DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2024. Quarterly Highlights Net sales for the quarter ended March 31, 2024, were $66.5 million, compared to $62.4 million for the fourth quarter in the prior year, an increase of 6.6%, driven by the acquisition of PetCareRx partially offset by a decline in PetMeds legacy sa
Caroline Conegliano Caroline Conegliano Umesh Sripad Umesh Sripad Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience,